Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 01, 2008 (Vol. 28, No. 15)

Improving R&D as well as Disease Prognosis

Biomarkers Are Being Leveraged at All Stages of Development as well as During Treatment

  • The identification and validation of biomarkers involved in cellular pathways has led to the development of targeted therapies for various cancers. This, in turn, has changed the paradigm of early drug discovery, patient selection for clinical trials, the road to FDA approval, and projected market potential. Many in the ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.